These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
43. Changes of salivary estrogen levels for detecting the fertile period. Günther V; Bauer I; Hedderich J; Mettler L; Schubert M; Mackelenbergh MT; Maass N; Alkatout I Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():38-42. PubMed ID: 26319654 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492 [TBL] [Abstract][Full Text] [Related]
45. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception. Bergquist C; Nillius SJ; Wide L; Lindgren A Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403 [TBL] [Abstract][Full Text] [Related]
46. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation. Fogel M; Rubin BL; Ossowski R Am J Obstet Gynecol; 1972 Mar; 112(5):629-39. PubMed ID: 5059593 [TBL] [Abstract][Full Text] [Related]
47. Determination of fertility interval with ovulation time estimation using differential skin surface temperature (DST) measurement. Shah A; Rao KH; Ruedi B; Magrini G Fertil Steril; 1984 May; 41(5):771-4. PubMed ID: 6714455 [TBL] [Abstract][Full Text] [Related]
48. Oestradiol in saliva during the menstrual cycle. Evans JJ; Stewart CR; Merrick AY Br J Obstet Gynaecol; 1980 Jul; 87(7):624-6. PubMed ID: 7426520 [TBL] [Abstract][Full Text] [Related]
49. Cervical mucus and prediction of the time of ovulation. Morishita H; Hashimoto T; Mitani H; Tanaka T; Higuchi K; Ozasa T Gynecol Obstet Invest; 1979; 10(4):157-62. PubMed ID: 527887 [TBL] [Abstract][Full Text] [Related]
50. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Reyes FI; Winter JS; Faiman C Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845 [TBL] [Abstract][Full Text] [Related]
51. The salivary ferning test and ovulation in clomiphene citrate-stimulated cycles. Pattanasuttinont S; Sereepapong W; Suwajanakorn S J Med Assoc Thai; 2007 May; 90(5):876-83. PubMed ID: 17596040 [TBL] [Abstract][Full Text] [Related]
52. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle. Grimes EM; Thompson IE; Taymor ML Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349 [TBL] [Abstract][Full Text] [Related]
53. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium. Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630 [TBL] [Abstract][Full Text] [Related]
54. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486. Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550 [TBL] [Abstract][Full Text] [Related]
55. Measurement of serum LH, FSH, progesterone, 17-hydroxy-progesterone and estradiol-17beta levels at 4-hour intervals during the periovulatory phase of the menstrual cycle. Thorneycroft IH; Sribyatta B; Tom WK; Nakamura RM; Mishell DR J Clin Endocrinol Metab; 1974 Oct; 39(4):754-8. PubMed ID: 4414601 [TBL] [Abstract][Full Text] [Related]
56. An assessment of the dual-analyte enzyme immunoassay for ovulation timing. Lenton EA; King H; Johnson J; Amos S Hum Reprod; 1989 May; 4(4):378-80. PubMed ID: 2663906 [TBL] [Abstract][Full Text] [Related]
57. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years. Barbosa I; Coutinho E; Hirsch C; Ladipo O; Olsson SE; Ulmsten U Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629 [TBL] [Abstract][Full Text] [Related]
58. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation. Croxatto HB; Salvatierra AM; Romero C; Spitz IM J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding. Lemay A; Faure N; Labrie F; Fazekas AT Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551 [TBL] [Abstract][Full Text] [Related]
60. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception. Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]